首页> 美国卫生研究院文献>Respiratory Medicine Case Reports >Intractable pleural effusion associated with superior vena cava and upper extremity deep vein thrombosis in a patient with advanced lung cancer
【2h】

Intractable pleural effusion associated with superior vena cava and upper extremity deep vein thrombosis in a patient with advanced lung cancer

机译:晚期肺癌患者顽固性胸腔积液与上腔静脉和上肢深静脉血栓形成相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We herein report a case with intractable pleural effusion attributed to superior vena cava (SVC) and upper extremity deep vein thrombosis in a patient with lung cancer. A 62-year-old woman presented to our hospital with shortness of breath and bilateral upper extremity edema. One year ago, she was diagnosed with stage IVB lung adenocarcinoma with bilateral malignant pleural effusions. A genetic analysis of the cells from pleural effusion revealed an epidermal growth factor receptor (EGFR) point mutation at exon 21 (L858R); since then, she was treated with gefitinib. Although her lung cancer and metastatic lesions had markedly reduced and the tumor cells in the pleural effusion had disappeared, pleural effusion remained. Contrast-enhanced whole-body computed tomography (CT) revealed intravenous thrombosis extending from the SVC to the left brachiocephalic and subclavian veins, and her pleural effusion was attributed to this thrombosis. Anticoagulant therapy with intravenous heparin and oral warfarin was started, nevertheless, the thrombus remained and pleural effusion did not decrease. After the placement of a pleuroperitoneal shunt, her pleural effusion resolved and her symptoms improved. This case highlights the importance of awareness of SVC or upper extremity deep vein thrombosis as a differential diagnosis of intractable pleural effusion in lung cancer patients.
机译:我们在此报告肺癌患者顽固性胸腔积液归因于上腔静脉(SVC)和上肢深静脉血栓形成的病例。一名62岁的妇女因呼吸急促和双侧上肢浮肿而到我院就诊。一年前,她被诊断为IVB期肺腺癌,并伴有双侧恶性胸腔积液。对来自胸腔积液的细胞进行的遗传分析显示,外显子21(L858R)处有表皮生长因子受体(EGFR)点突变;从那以后,她接受了吉非替尼治疗。尽管她的肺癌和转移灶明显减少,胸腔积液中的肿瘤细胞消失了,但胸腔积液仍然存在。对比增强的全身计算机断层扫描(CT)显示静脉血栓形成从SVC延伸到左头臂头和锁骨下静脉,而她的胸腔积液归因于这种血栓形成。开始使用静脉内肝素和口服华法林进行抗凝治疗,尽管如此,血栓仍然存在,胸腔积液并未减少。放置胸腹膜分流术后,胸腔积液消失,症状得到改善。该病例凸显了认识SVC或上肢深静脉血栓形成作为肺癌患者顽固性胸腔积液的鉴别诊断的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号